SAMH
ABBV icon

Shanda Asset Management Holdings’s AbbVie ABBV Stock Holding History

Shanda Asset Management Holdings’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-20,867
Closed -$2.05M – 52
2020
Q2 		$2.05M Buy
+20,867
New +$1.84M 0.18% 56
2016
Q2 		– Sell
-32,242
Closed -$1.84K – 27
2016
Q1 		$1.84K Hold
32,242
– – 0.2% 23
2015
Q4 		$1.91K Buy
+32,242
New +$1.86M 0.53% 18

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Shanda Asset Management Holdings's ABBV Position: Q3 2020 in Review

Shanda Asset Management Holdings sold out of AbbVie (ABBV) in Q3 2020, closing a stake of 20,867 shares — an estimated $2.05M sold.

Shanda Asset Management Holdings first reported a position in ABBV in Q4 2015 and held it in 3 quarters. The position peaked at $2.05M in Q2 2020. 2,366 funds tracked by Wall St. Rank hold ABBV as of Q3 2020.

  • Shanda Asset Management Holdings reported no remaining AbbVie position as of Q3 2020 after selling out during the quarter.
  • Shanda Asset Management Holdings sold 20,867 AbbVie shares in Q3 2020, an estimated $2.05M.
  • Shanda Asset Management Holdings first reported a position in AbbVie in Q4 2015 and held it in 3 quarters.
  • Shanda Asset Management Holdings's AbbVie position peaked at $2.05M in Q2 2020.
  • 2,366 funds tracked by Wall St. Rank held AbbVie as of Q3 2020.

Based on Shanda Asset Management Holdings's 13F filing for Q3 2020, filed 16 Nov 2020.